<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37296140</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A safe and effective micro-choice based rehabilitation for patients with long COVID: results from a quasi-experimental study.</ArticleTitle><Pagination><StartPage>9423</StartPage><MedlinePgn>9423</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9423</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-35991-y</ELocationID><Abstract><AbstractText>At least 65 million people suffer from long COVID. Treatment guidelines are unclear, especially pertaining to recommendations of increased activity. This longitudinal study evaluated safety, changes in functional level and sick leave following a concentrated rehabilitation program for patients with long COVID. Seventy-eight patients (19-67&#xa0;years) participated in a 3-day micro-choice based rehabilitation program with 7-day and 3-month follow-up. Fatigue, functional levels, sick leave, dyspnea and exercise capacity were assessed. No adverse events were reported and 97.4% completed the rehabilitation. Fatigue measured with Chalder Fatigue Questionnaire decreased at 7-days [mean difference (MD&#x2009;=&#x2009;- 4.5, 95% CI - 5.5 to - 3.4) and 3-month (MD&#x2009;=&#x2009;- 5.5, 95% CI - 6.7 to - 4.3). Sick leave rates and dyspnea were reduced (p&#x2009;&lt;&#x2009;0.001) and exercise capacity and functional level increased (p&#x2009;&lt;&#x2009;0.001) at 3-month follow-up regardless of severity of fatigue at baseline. Micro-choice based concentrated rehabilitation for patients with long COVID was safe, highly acceptable and showed rapid improvements in fatigue and functional levels, sustaining over time. Even though this is a quasi-experimental study, the findings are of importance addressing the tremendous challenges of disability due to long COVID. Our results are also highly relevant for patients, as they provide the base for an optimistic outlook and evidence supported reason for hope.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Frisk</LastName><ForeName>Bente</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Health and Functioning, Western Norway University for Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helse i Hardanger, &#xd8;ystese, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>J&#xfc;rgensen</LastName><ForeName>Marte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, &#xd8;ystese, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divison of Psychiatry, Haukeland University Hospital, PO Box 1400, 5021, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espehaug</LastName><ForeName>Birgitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Health and Functioning, Western Norway University for Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nj&#xf8;ten</LastName><ForeName>Kiri Lovise</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Health and Functioning, Western Norway University for Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helse i Hardanger, &#xd8;ystese, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;fteland</LastName><ForeName>Eirik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, &#xd8;ystese, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarli</LastName><ForeName>Bernt B&#xf8;gvald</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kvale</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Divison of Psychiatry, Haukeland University Hospital, PO Box 1400, 5021, Bergen, Norway. gerd.kvale@helse-bergen.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Psychology, University of Bergen, Bergen, Norway. gerd.kvale@helse-bergen.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Bernt B&#xf8;gvald Aarli has received Grants, consulting fees or honoraria from Boehringer Ingelheim, GlaxoSmithKline, Astra Zeneca, Novartis and Sanofi-Aventis. Bente Frisk, Marte J&#xfc;rgensen, Birgitte Espehaug, Kiri Lovise Nj&#xf8;ten, Eirik S&#xf8;fteland and Gerd Kvale have none competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37296140</ArticleId><ArticleId IdType="pmc">PMC10252160</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-35991-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-35991-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. AClinicalCaseDefinitionofPostCOVID-19ConditionbyaDelphiConsensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir. Med. 2022 doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur. J. Epidemiol. 2022;37:539&#x2013;548. doi: 10.1007/s10654-022-00847-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21:1&#x2013;9. doi: 10.1186/s12889-021-11013-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11013-2</ArticleId><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mhanna, S. B. etal. in Healthcare. 2130 (MDPI).</Citation></Reference><Reference><Citation>Compagno S, et al. Physical and psychological reconditioning in long COVID syndrome: Results of an out-of-hospital exercise and psychological-based rehabilitation program. IJC Heart Vasc. 2022;41:101080. doi: 10.1016/j.ijcha.2022.101080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101080</ArticleId><ArticleId IdType="pmc">PMC9286763</ArticleId><ArticleId IdType="pubmed">35854691</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E, Gerlis C, Chaplin E, Gardiner N, Singh SJ. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition&#x2014;a cohort study. Chron. Respir. Dis. 2021;18:14799731211015691. doi: 10.1177/14799731211015691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211015691</ArticleId><ArticleId IdType="pmc">PMC8114752</ArticleId><ArticleId IdType="pubmed">33957805</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugazzaro S, et al. Rehabilitation interventions for post-acute COVID-19 syndrome: A systematic review. Int. J. Environ. Res. Public Health. 2022 doi: 10.3390/ijerph19095185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095185</ArticleId><ArticleId IdType="pmc">PMC9104923</ArticleId><ArticleId IdType="pubmed">35564579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, et al. Benefits of pulmonary rehabilitation in COVID-19: A prospective observational cohort study. ERJ Open Res. 2021;7:25. doi: 10.1183/23120541.00108-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00108-2021</ArticleId><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Harenwall S, et al. Post-covid-19 syndrome: Improvements in health-related quality of life following psychology-led interdisciplinary virtual rehabilitation. J. Prim. Care Community Health. 2021;12:21501319211067674. doi: 10.1177/21501319211067674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319211067674</ArticleId><ArticleId IdType="pmc">PMC8721676</ArticleId><ArticleId IdType="pubmed">34939506</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, et al. Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized controlled trial. Scand. J. Med. Sci. Sports. 2022;20:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538729</ArticleId><ArticleId IdType="pubmed">36111386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammi P, et al. Post-COVID-19 ongoing symptoms and health-related quality of life: Does rehabilitation matter?: Preliminary evidence. Am. J. Phys. Med. Rehabil. 2023;102:241&#x2013;244. doi: 10.1097/PHM.0000000000002089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000002089</ArticleId><ArticleId IdType="pmc">PMC9940786</ArticleId><ArticleId IdType="pubmed">36002109</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, et al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101:593&#x2013;601. doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;20:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and long COVID: A cross-sectional study. Int. J. Environ. Res. Public Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvale G, et al. Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention study. JMIR Res. Protoc. 2021;10:e32216. doi: 10.2196/32216.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/32216</ArticleId><ArticleId IdType="pmc">PMC8500350</ArticleId><ArticleId IdType="pubmed">34505838</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubhaug B, Lier HO, A&#xdf;mus J, Rongve A, Kvale G. A 4-day mindfulness-based cognitive behavioral intervention program for CFS/ME: An open study, with 1-year follow-up. Front. Psychiatry. 2018;9:720. doi: 10.3389/fpsyt.2018.00720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00720</ArticleId><ArticleId IdType="pmc">PMC6306445</ArticleId><ArticleId IdType="pubmed">30618889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen B, et al. The Bergen 4-day treatment for panic disorder: A pilot study. Front. Psychol. 2018;3(9):639. doi: 10.3389/fpsyg.2018.00639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.00639</ArticleId><ArticleId IdType="pmc">PMC6029556</ArticleId><ArticleId IdType="pubmed">29997546</ArticleId></ArticleIdList></Reference><Reference><Citation>Launes G, et al. A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: The Bergen 4-day treatment. Front. Psychol. 2019;15(10):2500. doi: 10.3389/fpsyg.2019.02500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2019.02500</ArticleId><ArticleId IdType="pmc">PMC6873786</ArticleId><ArticleId IdType="pubmed">31803089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvale G, et al. Concentrated transdiagnostic and cross-disciplinary group treatment for patients with depression and with anxiety: A pilot study. BMC Psychiatry. 2022;22:1&#x2013;11. doi: 10.1186/s12888-022-04229-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-022-04229-y</ArticleId><ArticleId IdType="pmc">PMC9441319</ArticleId><ArticleId IdType="pubmed">36058925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, et al. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147&#x2013;153. doi: 10.1016/0022-3999(93)90081-p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-p</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Loge JH, Ekeberg &#xd8;, Kaasa S. Fatigue in the general Norwegian population: Normative data and associations. J. Psychosom. Res. 1998;45:53&#x2013;65. doi: 10.1016/S0022-3999(97)00291-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(97)00291-2</ArticleId><ArticleId IdType="pubmed">9720855</ArticleId></ArticleIdList></Reference><Reference><Citation>Tack M, Tuller DM, Struthers C. Bias caused by reliance on patient-reported outcome measures in non-blinded randomized trials: An in-depth look at exercise therapy for chronic fatigue syndrome. Fatigue Biomed. Health Behav. 2020;8:181&#x2013;192. doi: 10.1080/21641846.2020.1848262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1848262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: A simple measure of impairment in functioning. Br. J. Psychiatry. 2002;180:461&#x2013;464. doi: 10.1192/bjp.180.5.461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.180.5.461</ArticleId><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tack M, Tuller DM. PRINCE Secondary: Transdiagnostic CBT is not effective for persistent physical symptoms. Psychol. Med. 2021;20:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">34399862</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J. Chronic Dis. 1987;40:1129&#x2013;1133. doi: 10.1016/0021-9681(87)90080-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90080-4</ArticleId><ArticleId IdType="pubmed">3680471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581&#x2013;586. doi: 10.1136/thx.54.7.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: Development and initial testing of the Dyspnoea-12. Thorax. 2010;65:21&#x2013;26. doi: 10.1136/thx.2009.118521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.118521</ArticleId><ArticleId IdType="pmc">PMC2795166</ArticleId><ArticleId IdType="pubmed">19996336</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MT, et al. Dyspnoea-12 and multidimensional dyspnea profile: Systematic review of use and properties. J. Pain Symptom Manage. 2022;63:e75&#x2013;e87. doi: 10.1016/j.jpainsymman.2021.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2021.06.023</ArticleId><ArticleId IdType="pubmed">34273524</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, et al. Standardisation of spirometry. Eur. Respir. J. 2005;26:319&#x2013;338. doi: 10.1183/09031936.05.00034805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Albouaini K, Egred M, Alahmar A, Wright DJ. Cardiopulmonary exercise testing and its application. Postgrad. Med. J. 2007;83:675&#x2013;682. doi: 10.1136/hrt.2007.121558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2007.121558</ArticleId><ArticleId IdType="pmc">PMC2734442</ArticleId><ArticleId IdType="pubmed">17989266</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg G. Borg's Perceived Exertion and Pain Scales. Human Kinetics; 1998.</Citation></Reference><Reference><Citation>Edvardsen E, et al. Reference values for cardiorespiratory response and fitness on the treadmill in a 20- to 85-year-old population. Chest. 2013;144:241&#x2013;248. doi: 10.1378/chest.12-1458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-1458</ArticleId><ArticleId IdType="pubmed">23287878</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur. Respir. Rev. 2019;28:25. doi: 10.1183/16000617.0101-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0101-2018</ArticleId><ArticleId IdType="pmc">PMC9488712</ArticleId><ArticleId IdType="pubmed">31852745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tveter AT, Dagfinrud H, Moseng T, Holm I. Measuring health-related physical fitness in physiotherapy practice: Reliability, validity, and feasibility of clinical field tests and a patient-reported measure. J. Orthop. Sports Phys. Ther. 2014;44:206&#x2013;216. doi: 10.2519/jospt.2014.5042.</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2014.5042</ArticleId><ArticleId IdType="pubmed">24450369</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjelltveit EB, et al. Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection&#x2014;a case&#x2013;control study. Clin. Infect. Dis. 2022 doi: 10.1093/cid/ciac655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac655</ArticleId><ArticleId IdType="pmc">PMC9384725</ArticleId><ArticleId IdType="pubmed">35959897</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen K, et al. Changes in mental health symptoms from April (COVID-19 outbreak) to December 2020 in Norway: A two-wave study. Cogent Psychol. 2023;10:2173998. doi: 10.1080/23311908.2023.2173998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23311908.2023.2173998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampf G, Kulldorff M. Calling for benefit&#x2013;risk evaluations of COVID-19 control measures. Lancet. 2021;397:576&#x2013;577. doi: 10.1016/S0140-6736(21)00193-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00193-8</ArticleId><ArticleId IdType="pmc">PMC7906630</ArticleId><ArticleId IdType="pubmed">33549169</ArticleId></ArticleIdList></Reference><Reference><Citation>Paltrinieri S, et al. Beyond lockdown: The potential side effects of the SARS-CoV-2 pandemic on public health. Nutrients. 2021;13:1600. doi: 10.3390/nu13051600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13051600</ArticleId><ArticleId IdType="pmc">PMC8170902</ArticleId><ArticleId IdType="pubmed">34064715</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe M, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomised controlled trial. BMJ. 1996;312:22&#x2013;26. doi: 10.1136/bmj.312.7022.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.312.7022.22</ArticleId><ArticleId IdType="pmc">PMC2349693</ArticleId><ArticleId IdType="pubmed">8555852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>